Literature DB >> 14607640

Curative resection of pancreatic head carcinoma in recent 30 years: report of 377 cases.

Quan-Xing Ni1, Qun-Hua Zhang, De-Liang Fu, Guo-Hai Cao, Qi-Yuan Yao, Chen Jin, Xian-Jun Yu, Niu Zhang, Yan-Ling Zhang.   

Abstract

OBJECTIVE: To evaluate retrospectively the relationship between the types of operation, characteristics of tumor, and survival rate after radical pancreatoduodenectomy for patients with carcinoma of the pancreatic head performed in recent 30 years.
METHODS: Of 377 patients with carcinoma of the pancreas treated during 1970-1999, 75 were subjected to Whipple procedure or pancreatectomy with dissection of regional lymph nodes (10 patients receiving intervention therapy). The latter is beneficial to patients with carcinoma of the pancreatic head. The operation may be extended by resection of a segment of superior mensenteric-portal vein confluence if involved.
RESULTS: The resection rate was increased from 9% in the 1970s to 28.2% in the 1990s. The 1-, 3-, 5-year-survival rates were 50%, 25%, 0 in the 1970s; 57.1%, 28.5%, 9% in the 1980s; and 61.1%, 27%, 11.1% in the 1990s, respectively.
CONCLUSION: Despite its retrospective in nature, the present study suggests that in patients with pancreatic cancer without visceral or distant metastasis, resection should always be at tempted when there is no high operative risk factor and the operation is technically feasible.

Entities:  

Mesh:

Year:  2002        PMID: 14607640

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  4 in total

Review 1.  Intraoperative assessment of the Whipple resection specimen.

Authors:  Mahmoud A Khalifa
Journal:  J Clin Pathol       Date:  2007-03-16       Impact factor: 3.411

2.  Improved lymph node retrieval in Whipple specimens as a result of implementation of a new uncinate margin protocol.

Authors:  Corwyn H Rowsell; Sherif Hanna; Eugene Hsieh; Calvin Law; Mahmoud A Khalifa
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

3.  Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study.

Authors:  Sung Hoon Jeong; Hyeon Ji Lee; Choa Yun; Il Yun; Yun Hwa Jung; Soo Young Kim; Hee Seung Lee; Sung-In Jang
Journal:  BMC Cancer       Date:  2022-08-27       Impact factor: 4.638

4.  The incidence and survival rate of population-based pancreatic cancer patients: Shanghai Cancer Registry 2004-2009.

Authors:  Jianfeng Luo; Linhai Xiao; Chunxiao Wu; Ying Zheng; Naiqing Zhao
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.